<SEC-DOCUMENT>0001354457-15-000226.txt : 20151124
<SEC-HEADER>0001354457-15-000226.hdr.sgml : 20151124
<ACCEPTANCE-DATETIME>20151124094655
ACCESSION NUMBER:		0001354457-15-000226
CONFORMED SUBMISSION TYPE:	25-NSE
CONFIRMING COPY:	
PUBLIC DOCUMENT COUNT:		2
FILED AS OF DATE:		20151124
DATE AS OF CHANGE:		20151124

SUBJECT COMPANY:	

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			ONCOLYTICS BIOTECH INC
		CENTRAL INDEX KEY:			0001129928
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				000000000
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		25-NSE
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-31062

	BUSINESS ADDRESS:	
		STREET 1:		1167 KENSINGTON CRES NW SUITE 210
		STREET 2:		CALGARY ALBERTA CANADA T2N 1X7
		CITY:			ALBERTA CANADA
		STATE:			A0
		ZIP:			00000
		BUSINESS PHONE:		4036707380

	MAIL ADDRESS:	
		STREET 1:		210 - 1167 KENSINGTON CRES NW
		CITY:			CALGARY
		STATE:			A0
		ZIP:			T2N 1X7

FILED BY:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			NASDAQ Stock Market LLC
		CENTRAL INDEX KEY:			0001354457
		IRS NUMBER:				521165937
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		25-NSE

	BUSINESS ADDRESS:	
		STREET 1:		9600 BLACKWELL RD
		CITY:			ROCKVILLE
		STATE:			MD
		ZIP:			20850
		BUSINESS PHONE:		301-978-4144

	MAIL ADDRESS:	
		STREET 1:		9600 BLACKWELL RD
		CITY:			ROCKVILLE
		STATE:			MD
		ZIP:			20850
</SEC-HEADER>
<DOCUMENT>
<TYPE>25-NSE
<SEQUENCE>1
<FILENAME>primary_doc.xml
<TEXT>
<XML>
<?xml version="1.0"?>
<notificationOfRemoval>

    <schemaVersion>X0203</schemaVersion>

    <exchange>
        <cik>0001354457</cik>
        <entityName>NASDAQ Stock Market LLC</entityName>
    </exchange>

    <issuer>
        <cik>0001129928</cik>
        <entityName>ONCOLYTICS BIOTECH INC</entityName>
        <fileNumber>000-31062</fileNumber>
        <address>
            <street1>210, 1167 Kensington Cresent N.W.</street1>
            <street2></street2>
            <city>Calgary</city>
            <stateOrCountryCode>A0</stateOrCountryCode>
            <stateOrCountry>ALBERTA, CANADA</stateOrCountry>
            <zipCode>T2N 1X7</zipCode>
        </address>
        <telephoneNumber>4036707374</telephoneNumber>
    </issuer>

    <descriptionClassSecurity>Common Stock</descriptionClassSecurity>

    <ruleProvision>17 CFR 240.12d2-2(b)</ruleProvision>

    <signatureData>
        <signatureName>Amy Horton</signatureName>
        <signatureTitle>Hearings Advisor</signatureTitle>
        <signatureDate>2015-11-24</signatureDate>
    </signatureData>
</notificationOfRemoval>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.25
<SEQUENCE>2
<FILENAME>oncydelistreason.txt
<TEXT>
Delisting Determination,The Nasdaq Stock Market, LLC,
November 24, 2015, Oncolytics Biotech, Inc. The Nasdaq Stock
Market, Inc. (the Exchange) has determined to remove
from listing the common stock of Oncolytics Biotech, Inc.
(the Company), effective at the opening of the
trading session on December 4, 2015. Based on review of information
provided by the Company, Nasdaq Staff determined that the
Company no longer qualified for listing on the Exchange
pursuant to Listing Rule 5550(a)(2).
The Company was notified of the Staffs determination on
October 27, 2015. The Company did not appeal the Staff
determination to the Hearings Panel, and the Staff
determination to delist the Company became final on
November 5, 2015.

</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
